Your browser doesn't support javascript.
loading
[Retracted] MicroRNA­199a­3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1.
He, Yanfang; Yu, Xiangyang; Tang, Yajuan; Guo, Yanjuan; Yuan, Jinling; Bai, Jinghe; Yao, Tao; Wu, Xiongzhi.
Afiliación
  • He Y; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, P.R. China.
  • Yu X; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Tang Y; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Guo Y; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Yuan J; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Bai J; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Yao T; Department of Obstetrics and Gynecology, Affiliated Hospital of North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.
  • Wu X; Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300000, P.R. China.
Mol Med Rep ; 27(1)2023 Jan.
Article en En | MEDLINE | ID: mdl-36367157
Following the publication of the above article, the authors have submitted a request that it be retracted on account of the fact that, when requested to do so, the first author was unable to provide the original data for this article. The Editor of Molecular Medicine Reports has agreed with the request that this article be retracted. Note that all the authors agree with the decision to retract this article. The Editor and the authors regret any inconvenience that this retraction will cause to the readership of the Journal. [Molecular Medicine Reports 23: 237, 2021; DOI: 10.3892/mmr.2021.11876].
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Med Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Med Rep Año: 2023 Tipo del documento: Article